Pear Therapeutics and Thimble Point Acquisition Corp. Announce Effectiveness of S-4 Registration Statement and Set November 23, 2021 for Thimble Point Special Stockholder Meeting to Vote on Proposed B Oct 27, 2021 08:00AM
Pear Therapeutics to Become Public Company via Merger with Thimble Point Acquisition Corp. (THMA) Jun 22, 2021 07:05AM
Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics Jun 22, 2021 07:00AM
Thimble Point Acquisition Corp. Announces the Separate Trading of Its Class A Common Stock and Warrants, Commencing on or About March 25, 2021 Mar 22, 2021 05:07PM
Thimble Point Acquisition Corp. Announces Closing of Upsized $276 Million Initial Public Offering Feb 4, 2021 04:30PM


Feb 2, 2021 05:47AM Thimble Point Acquisition Corp. (THMA) Prices 24M Unit Upsized IPO at $10/Unit
Feb 1, 2021 09:05PM Thimble Point Acquisition Corp. Announces Pricing of Upsized $240 Million Initial Public Offering